These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 25900221)

  • 21. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates.
    Bellevicine C; Iaccarino A; Malapelle U; Sasso FC; Biondi B; Troncone G
    Eur J Endocrinol; 2013 Sep; 169(3):307-11. PubMed ID: 23811186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations.
    Song DH; Lee B; Shin Y; Choi IH; Ha SY; Lee JJ; Hong ME; Choi YL; Han J; Um SW
    Diagn Cytopathol; 2015 Jul; 43(7):539-44. PubMed ID: 25427298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study.
    Addati T; Achille G; Centrone M; Petroni S; Popescu O; Russo S; Grammatica L; Simone G
    Cytopathology; 2015 Oct; 26(5):303-11. PubMed ID: 25164548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma.
    Das DK; Al-Waheeb SK; George SS; Haji BI; Mallik MK
    Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material.
    Sathiyamoorthy S; Maleki Z
    Diagn Cytopathol; 2014 Jan; 42(1):5-10. PubMed ID: 23637102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.
    Krane JF; Cibas ES; Alexander EK; Paschke R; Eszlinger M
    Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control.
    Cochand-Priollet B; Dahan H; Laloi-Michelin M; Polivka M; Saada M; Herman P; Guillausseau PJ; Hamzi L; Poté N; Sarfati E; Wassef M; Combe H; Raulic-Raimond D; Chedin P; Medeau V; Casanova D; Kania R
    Thyroid; 2011 Oct; 21(10):1067-73. PubMed ID: 21875347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
    Smith GD; Zhou L; Rowe LR; Jarboe EA; Collins BT; Bentz JS; Wittwer CT; Chadwick BE
    Acta Cytol; 2011; 55(6):576-83. PubMed ID: 22156469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Accuracy of Fine Needle Aspiration in Thyroid Nodules Arising in Patients with Graves Disease.
    Hang JF; Lilo MT; Bishop JA; Ali SZ
    Acta Cytol; 2017; 61(2):117-124. PubMed ID: 28259878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
    Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
    Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid fine-needle aspiration cytology mimicking thyroid papillary cancer in a lung cancer patient.
    Hsu CY; Lin CL; Tsai ML; Huang SH
    Diagn Cytopathol; 2017 Mar; 45(3):217-220. PubMed ID: 28211232
    [No Abstract]   [Full Text] [Related]  

  • 36. Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
    Buryk MA; Simons JP; Picarsic J; Monaco SE; Ozolek JA; Joyce J; Gurtunca N; Nikiforov YE; Feldman Witchel S
    Thyroid; 2015 Apr; 25(4):392-400. PubMed ID: 25627462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
    Meng Z; Lu J; Wu H; Zhao Y; Luo Y; Gao J; Zhu Q; Jiang Y; Li W; Liang Z
    Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic lung carcinoma in thyroid aspirates: A case series and literature review illustrating diagnostic challenges.
    Ng JKM; Li JJX
    Cytopathology; 2022 Nov; 33(6):696-706. PubMed ID: 35808980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse sclerosing variant of papillary thyroid carcinoma: a study of fine needle aspiration cytology in 20 patients.
    Takagi N; Hirokawa M; Nobuoka Y; Higuchi M; Kuma S; Miyauchi A
    Cytopathology; 2014 Jun; 25(3):199-204. PubMed ID: 23781895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.